Wells Fargo & Company Trans Medics Group, Inc. Transaction History

Wells Fargo & Company

$429 Billion
Q1 2025

A detailed history of Wells Fargo & Company transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 213,270 shares of TMDX stock, worth $27.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

213,270

Previous 169,478 25.84%

Holding current value

$27.4 Million

Previous $10.6 Million 35.79%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$56.73 - $79.42 $2.48 Million - $3.48 Million	43,792 Added 25.84%	213,270 $14.3 Million
Q4 2024 Feb 12, 2025	BUY	$59.28 - $144.9 $2.18 Million - $5.32 Million	36,722 Added 27.66%	169,478 $10.6 Million
Q3 2024 Nov 13, 2024	BUY	$135.68 - $176.11 $987,072 - $1.28 Million	7,275 Added 5.8%	132,756 $20.8 Million
Q2 2024 Aug 13, 2024	SELL	$72.62 - $150.62 $3.77 Million - $7.81 Million	-51,857 Reduced 29.24%	125,481 $18.9 Million
Q1 2024 May 10, 2024	SELL	$70.86 - $89.93 $1.24 Million - $1.58 Million	-17,542 Reduced 9.0%	177,338 $13.1 Million
Q4 2023 Feb 09, 2024	SELL	$36.74 - $81.08 $9,515 - $20,999	-259 Reduced 0.13%	194,880 $15.4 Million
Q3 2023 Nov 13, 2023	BUY	$53.47 - $96.07 $619,931 - $1.11 Million	11,594 Added 6.32%	195,139 $10.7 Million
Q2 2023 Aug 15, 2023	BUY	$66.23 - $88.73 $10.7 Million - $14.3 Million	160,987 Added 713.66%	183,545 $15.4 Million
Q1 2023 May 12, 2023	BUY	$53.63 - $82.33 $104,524 - $160,461	1,949 Added 9.46%	22,558 $1.71 Million
Q4 2022 Feb 13, 2023	SELL	$39.08 - $64.29 $814,544 - $1.34 Million	-20,843 Reduced 50.28%	20,609 $1.27 Million
Q3 2022 Nov 14, 2022	BUY	$31.56 - $55.75 $1.03 Million - $1.83 Million	32,746 Added 376.13%	41,452 $1.73 Million
Q2 2022 Aug 12, 2022	SELL	$20.56 - $32.15 $216,394 - $338,378	-10,525 Reduced 54.73%	8,706 $274,000
Q1 2022 May 16, 2022	SELL	$12.58 - $26.94 $111,458 - $238,688	-8,860 Reduced 31.54%	19,231 $518,000
Q4 2021 Feb 14, 2022	BUY	$19.16 - $32.68 $310,928 - $530,331	16,228 Added 136.8%	28,091 $538,000
Q3 2021 Nov 15, 2021	BUY	$25.92 - $34.51 $63,633 - $84,722	2,455 Added 26.09%	11,863 $392,000
Q2 2021 Aug 16, 2021	SELL	$21.63 - $40.07 $151,604 - $280,850	-7,009 Reduced 42.69%	9,408 $313,000
Q1 2021 May 13, 2021	SELL	$17.75 - $47.82 $533,405 - $1.44 Million	-30,051 Reduced 64.67%	16,417 $681,000
Q4 2020 Feb 09, 2021	BUY	$11.91 - $19.9 $125,579 - $209,825	10,544 Added 29.35%	46,468 $924,000
Q3 2020 Nov 05, 2020	SELL	$13.78 - $18.84 $89,266 - $122,045	-6,478 Reduced 15.28%	35,924 $495,000
Q2 2020 Aug 13, 2020	BUY	$11.66 - $18.26 $253,756 - $397,392	21,763 Added 105.45%	42,402 $760,000
Q1 2020 May 14, 2020	BUY	$10.5 - $20.2 $216,709 - $416,907	20,639 New	20,639 $250,000

Others Institutions Holding TMDX

# of Institutions

338

Shares Held

32.1M

Call Options Held

852K

Put Options Held

690K

View Full List

About TransMedics Group, Inc.

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $4.09B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

More about TMDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Trans Medics Group, Inc. Transaction History